BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 26474696)

  • 21. Piperlongumine alleviates lupus nephritis in MRL-Fas(lpr) mice by regulating the frequency of Th17 and regulatory T cells.
    Yao L; Chen HP; Ma Q
    Immunol Lett; 2014 Sep; 161(1):76-80. PubMed ID: 24837470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Th17 and Th1 cells in systemic lupus erythematosus with focus on lupus nephritis.
    Fakhfakh R; Zian Z; Elloumi N; Abida O; Bouallegui E; Houssaini H; Volpe E; Capone A; Hachicha H; Marzouk S; Bahloul Z; Masmoudi H
    Immunol Res; 2022 Oct; 70(5):644-653. PubMed ID: 35666434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic potential of DCB-SLE1, an extract of a mixture of Chinese medicinal herbs, for severe lupus nephritis.
    Tsai PY; Ka SM; Chang JM; Chang WL; Huang YJ; Hung LM; Jheng HL; Wu RY; Chen A
    Am J Physiol Renal Physiol; 2011 Oct; 301(4):F751-64. PubMed ID: 21677146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clear suppression of Th1 responses but marginal amelioration of autoimmune manifestations by IL-12p40 transgene in MRL-FAS(lprcg)/FAS(lprcg) mice.
    Yasuda T; Yoshimoto T; Tsubura A; Matsuzawa A
    Cell Immunol; 2001 Jun; 210(2):77-86. PubMed ID: 11520074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity.
    Talaat RM; Mohamed SF; Bassyouni IH; Raouf AA
    Cytokine; 2015 Apr; 72(2):146-53. PubMed ID: 25647269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The gene expression of type 17 T-helper cell-related cytokines in the urinary sediment of patients with systemic lupus erythematosus.
    Kwan BC; Tam LS; Lai KB; Lai FM; Li EK; Wang G; Chow KM; Li PK; Szeto CC
    Rheumatology (Oxford); 2009 Dec; 48(12):1491-7. PubMed ID: 19773408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-33 alleviates DSS-induced chronic colitis in C57BL/6 mice colon lamina propria by suppressing Th17 cell response as well as Th1 cell response.
    Zhu J; Wang Y; Yang F; Sang L; Zhai J; Li S; Li Y; Wang D; Lu C; Sun X
    Int Immunopharmacol; 2015 Dec; 29(2):846-853. PubMed ID: 26359542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 5,6,7,8-Tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidine derivative attenuates lupus nephritis with less effect to thymocyte development.
    Wei F; Zhou X; Chen H; Tian X; Liu Z; Yu B; He X; Bai C; Huang Z
    Immunol Res; 2021 Aug; 69(4):378-390. PubMed ID: 34219199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 3
    Zhou X; Chen H; Wei F; Zhao Q; Su Q; Liang J; Yin M; Tian X; Liu Z; Yu B; Bai C; He X; Huang Z
    J Immunol Res; 2019; 2019():2431617. PubMed ID: 31240232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis.
    Enghard P; Langnickel D; Riemekasten G
    Scand J Rheumatol; 2006; 35(3):209-16. PubMed ID: 16766368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of nonmyeloablative unrelated fetal and neonatal murine peripheral blood mononuclear cell infusion on MRL/lpr mice.
    Chuan W; Wu-qing W; Zhu-wen Y; Zuo L
    Lupus; 2014 Sep; 23(10):994-1005. PubMed ID: 24756437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dehydrodiconiferyl alcohol (DHCA) modulates the differentiation of Th17 and Th1 cells and suppresses experimental autoimmune encephalomyelitis.
    Lee J; Choi J; Lee W; Ko K; Kim S
    Mol Immunol; 2015 Dec; 68(2 Pt B):434-44. PubMed ID: 26477735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Th-17 related regulatory network in the pathogenesis of Arab patients with systemic lupus erythematosus and lupus nephritis.
    AlFadhli S; AlFailakawi A; Ghanem AA
    Int J Rheum Dis; 2016 May; 19(5):512-20. PubMed ID: 25496163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Administration of an IL-12-encoding DNA plasmid prevents the development of chronic graft-versus-host disease (GVHD).
    Okubo T; Hagiwara E; Ohno S; Tsuji T; Ihata A; Ueda A; Shirai A; Aoki I; Okuda K; Miyazaki J; Ishigatsubo Y
    J Immunol; 1999 Apr; 162(7):4013-7. PubMed ID: 10201922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complement component C5a permits the coexistence of pathogenic Th17 cells and type I IFN in lupus.
    Pawaria S; Ramani K; Maers K; Liu Y; Kane LP; Levesque MC; Biswas PS
    J Immunol; 2014 Oct; 193(7):3288-95. PubMed ID: 25149466
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intrinsic Differences in Donor CD4 T Cell IL-2 Production Influence Severity of Parent-into-F1 Murine Lupus by Skewing the Immune Response Either toward Help for B Cells and a Sustained Autoantibody Response or toward Help for CD8 T Cells and a Downregulatory Th1 Response.
    Soloviova K; Puliaiev M; Haas M; Dalgard CL; Schaefer BC; Via CS
    J Immunol; 2015 Oct; 195(7):2985-3000. PubMed ID: 26320249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T-bet is critical for the development of acute graft-versus-host disease through controlling T cell differentiation and function.
    Fu J; Wang D; Yu Y; Heinrichs J; Wu Y; Schutt S; Kaosaard K; Liu C; Haarberg K; Bastian D; McDonald DG; Anasetti C; Yu XZ
    J Immunol; 2015 Jan; 194(1):388-97. PubMed ID: 25404360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-T cell receptor antibody treatment of mice with lupus-like graft versus host disease: suppression of glomerulonephritis without reduction in anti-DNA antibody levels.
    Maeda T; Nomoto K
    J Rheumatol; 1995 Dec; 22(12):2259-65. PubMed ID: 8835559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carbon monoxide-releasing molecule-A1 inhibits Th1/Th17 and stimulates Th2 differentiation in vitro.
    Nikolic I; Vujicic M; Stojanovic I; Stosic-Grujicic S; Saksida T
    Scand J Immunol; 2014 Aug; 80(2):95-100. PubMed ID: 24845722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glucocorticoids enhance Th17/Th1 imbalance and signal transducer and activator of transcription 3 expression in systemic lupus erythematosus patients.
    Prado C; de Paz B; Gómez J; López P; Rodríguez-Carrio J; Suárez A
    Rheumatology (Oxford); 2011 Oct; 50(10):1794-801. PubMed ID: 21750002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.